Literature DB >> 3149770

Effects of cholinergic and anticholinergic drugs on ketamine-induced linguopharyngeal motor activity.

L A Marco1, R S Joshi, C Brown, L D Aldes, R B Chronister.   

Abstract

Benztropine mesylate (Cogentin) and physostigmine salicylate (Antilirium), were tested for changes in tongue protrusions, retrusions, and swallowing acts in rats anesthetized with a 100 mg/kg IM injection of ketamine hydrochloride. These ketamine-induced linguopharyngeal events were monitored by means of a force displacement transducer fed onto a polygraph. Benztropine (0.05-1 mg/kg) caused mild to moderate reductions in the rate of these events for a short period of time, up to about 30 min. With physostigmine (5-25 micrograms/kg), linguopharyngeal activity was markedly increased, up to 50-fold by the highest dose within 5 min and returned almost to the baseline within 60 min. With lower doses, more moderate responses were obtained. If methscopolamine (1.4, 3, 6 mg/kg IM) preceded physostigmine, the physostigmine enhancement was preserved.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3149770     DOI: 10.1007/bf02180028

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  17 in total

1.  Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia.

Authors:  J Gerlach; N Reisby; A Randrup
Journal:  Psychopharmacologia       Date:  1974-01-09

2.  Cholinergic suppression of tardive dyskinesia.

Authors:  W E Fann; C R Lake; C J Gerber; G M McKenzie
Journal:  Psychopharmacologia       Date:  1974-06-21

3.  Physostigmine in choreiform movement disorders.

Authors:  D Tarsy; N Leopold; D S Sax
Journal:  Neurology       Date:  1974-01       Impact factor: 9.910

Review 4.  Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature.

Authors:  G E Crane
Journal:  Am J Psychiatry       Date:  1968-02       Impact factor: 18.112

5.  Observations on the effect of levodopa on tardive lingual-facial-buccal dyskinesia.

Authors:  H L Klawans; R R McKendall
Journal:  J Neurol Sci       Date:  1971-10       Impact factor: 3.181

Review 6.  Animal models of tardive dyskinesia: their use in the search for new treatment methods.

Authors:  C G Goetz; H L Klawans; P Carvey
Journal:  Mod Probl Pharmacopsychiatry       Date:  1983

7.  Monkey models of tardive dyskinesia.

Authors:  E F Domino; B Kovacic
Journal:  Mod Probl Pharmacopsychiatry       Date:  1983

8.  Lecithin can suppress tardive dyskinesia.

Authors:  J H Growdon; A J Gelenberg; J Doller; M J Hirsch; R J Wurtman
Journal:  N Engl J Med       Date:  1978-05-04       Impact factor: 91.245

9.  Abnormal involuntary movements induced by anticholinergic therapy.

Authors:  E Birket-Smith
Journal:  Acta Neurol Scand       Date:  1974       Impact factor: 3.209

10.  Effect of cholinergic and anticholinergic agents on tardive dyskinesia.

Authors:  H L Klawans; R Rubovits
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-08       Impact factor: 10.154

View more
  2 in total

1.  Adjunctive memantine therapy for cognitive impairment in chronic schizophrenia: a placebo-controlled pilot study.

Authors:  Jung Goo Lee; Sae Woom Lee; Bong Ju Lee; Sung Woo Park; Gyung Mee Kim; Young Hoon Kim
Journal:  Psychiatry Investig       Date:  2012-05-22       Impact factor: 2.505

2.  Study of the Effect of Memantine on Negative Sign in Patients with Schizophrenia and Schizoaffective Disorders.

Authors:  Maria Tavakoli-Ardakani; Hamide Abbaspour; Abdollah Farhadi Nasab; Azadeh Mazaheri Meibodi; Ali Kheradmand
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.